Greene Barry E

Greene Barry E is listed in filings as Director at Karyopharm Therapeutics Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including 8 public disclosures. Recent filings connect the profile to Karyopharm Therapeutics Inc. (KPTI) and Sage Therapeutics, Inc. (SAGE). The current snapshot covers public activity from Aug 7, 2024 to May 26, 2026. Reported amounts are shown as $1.2M to $164.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.